Literature DB >> 29729809

Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema.

John F Payne1, W Lloyd Clark2, Beau B Bruce3, Charles C Wykoff4, David M Brown4, Brandon M Menke5, Shawn M Iverson5, Keri F Allen5, David S Boyer6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29729809     DOI： 10.1016/j.ophtha.2018.03.046

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  1 in total

1.  Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections.

Authors:  Tatiana R Rosenblatt; Nadim Rayess; Ahmad Al-Moujahed; Rahul N Khurana; Prithvi Mruthyunjaya
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-20       Impact factor: 3.117
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.